Leptin and cancer: Pathogenesis and modulation

• Main Authors: Deep Dutta, Sujoy Ghosh, Kaushik Pandit, Pradip Mukhopadhyay, Subhankar Chowdhury
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2012-01-01
• Series: Indian Journal of Endocrinology and Metabolism
• Subjects: Breast cancer; colorectal cancer; hepatocellular cancer; leptin; thyroid cancer
• Online Access: http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=9;spage=596;epage=600;aulast=Dutta

Leptin, a product of Ob gene from adipocytes regulates appetite, energy expenditure and body mass composition by decreasing orexigenic and increasing anorexigenic neuropeptide release from hypothalamus. Research over the past few years have suggested leptin/leptin receptor dysregulation to have a role in the development of a large variety of malignancies like breast ca, thyroid ca, endometrial ca and gastrointestinal malignancies, predominantly through JAK/STAT pathway which modulates PI3K/AKT3 signaling, ERK1/2 signaling, expression of antiapoptotic proteins (like XIAP), systemic inflammation (TNF-α, IL6), angiogenic factors (VEGF) and hypoxia inducible factor-1a (HIF-1a) expression. In this review, the current understanding of leptin′s role in carcinogenesis has been elaborated. Also a few agents modulating leptin signaling to inhibit cancer cell growth has been described.